ArticleMedicine2026

Adverse events associated with the use of nivolumab in the middle-aged and older population (>45 years): A pharmacovigilance analysis based on the FAERS database.

Lei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.